Cannabis Users Face Higher Anesthesia Risks During Surgery, Doctors Warn

Anesthesia Dosing Challenges in Cannabis Patients

Regular cannabis users require 20-30% higher doses of propofol and other sedatives to achieve adequate anesthesia, creating a narrow margin between effective sedation and overdose risk. The phenomenon stems from THC's interaction with CB1 receptors in the central nervous system, which alters the brain's response to GABAergic anesthetics like propofol and benzodiazepines.

Anesthesiologists face a dosing dilemma. Underdosing leads to intraoperative awareness, where patients regain consciousness during surgery. Overdosing risks respiratory depression and cardiovascular collapse. Chronic cannabis use makes both outcomes more likely.

High-potency concentrates and daily use patterns intensify the problem. Patients consuming dabbed concentrates or vaping THC distillates multiple times daily show the most pronounced tolerance effects, according to the guidance.

Perioperative Complication Rates

Cannabis users experience airway complications at rates 50% higher than non-users, driven by chronic bronchial irritation and increased secretions during intubation. Smoking or vaping cannabis inflames airway tissues. That makes intubation more difficult and raises the risk of laryngospasm, a potentially fatal airway closure reflex.

Cardiovascular risks also climb. THC causes tachycardia and blood pressure fluctuations that complicate intraoperative hemodynamic management. When cannabis-induced tachycardia combines with anesthesia-induced vasodilation, the result can trigger myocardial ischemia in patients with underlying cardiac disease.

Postoperative pain control presents another hurdle. Cannabis users report higher pain scores and consume more opioids in recovery, likely due to cross-tolerance between cannabinoid and opioid receptor systems. Some surgical centers now require preoperative cannabis cessation protocols, though compliance remains inconsistent.

Disclosure Gaps and Clinical Protocols

Fewer than 40% of regular cannabis users disclose their consumption during preoperative assessments, creating blind spots for anesthesia teams. Stigma and legal concerns drive underreporting, even in states with legal adult-use markets. Older patients and those using cannabis for non-medical purposes show the lowest disclosure rates.

Surgical centers should adopt non-judgmental screening language and emphasize that disclosure directly affects patient safety, the guidance urges. Anesthesiologists recommend a minimum 72-hour abstinence window before elective procedures. Heavy users need longer cessation periods.

For full background on this issue, see the CannIntel topic hub on Cannabis and Anesthesia Surgery Risks. The hub tracks emerging research on cannabinoid-anesthetic interactions and state-level guidance for surgical centers.

The next variable to watch: whether states with medical cannabis programs will require dispensaries to provide surgical-risk warnings at point of sale, similar to alcohol and tobacco advisories.